HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Up-regulation and pre-activation of TRAF3 and TRAF5 in inflammatory bowel disease.

AbstractOBJECTIVE:
TRAF3 and TRAF5 share a common ancestral gene, and interact as essential components of signaling pathways in immunity. TRAF3 and TRAF5 are overexpressed in the colon of rat/mouse models with colitis. However, the expressions of TRAF3 and TRAF5 in patients with inflammatory bowel disease have not been elucidated. The aim of the present study is to explore the potential roles of TRAF3 and TRAF5 in patients with inflammatory bowel disease.
METHODS:
Plasma levels of TRAF3 and TRAF5 proteins were detected by Enzyme-linked Immunosorbent Assay (ELISA). Colonic expression of TRAF3 and TRAF5 proteins was detected by western blot analysis. Quantitative Real-time PCR (qRT-PCR) was applied for gene expression. Inflamed intestinal mucosa and non-inflamed intestinal mucosa in patients with inflammatory bowel disease and normal mucosa was analyzed from healthy controls.
RESULTS:
The plasma levels of TRAF3 and TRAF5 were significantly higher both in patients with Crohn's disease and ulcerative colitis than in healthy controls. Only soluble TRAF5 showed a weak correlation with endoscopic disease activity index (Baron score) in patients with ulcerative colitis (spearman's r=0.358, P=0.022). Gene expressions of TRAF3 and TRAF5 in peripheral blood mononuclear cells were significantly higher both in patients with Crohn's disease and ulcerative colitis than in healthy controls (all P<0.0001). Gene and protein expressions of TRAF3 and TRAF5 were significantly higher in inflamed colonic mucosa of patients with Crohn's disease and ulcerative colitis than in non-inflamed colonic mucosa and normal mucosa of healthy controls (all P<0.0001). Furthermore, gene and protein expressions of TRAF3 and TRAF5 were also significantly higher in non-inflamed colonic mucosa of patients with Crohn's disease and ulcerative colitis than in normal mucosa of healthy controls.
CONCLUSIONS:
TRAF3 and TRAF5 are overexpressed in inflammatory bowel disease. Although the endoscopic appearance can be normal, TRAF3 and TRAF5 pre-activation can be detected in non-inflamed colonic segments.
AuthorsJun Shen, Yu-qi Qiao, Zhi-hua Ran, Tian-rong Wang
JournalInternational journal of medical sciences (Int J Med Sci) Vol. 10 Issue 2 Pg. 156-63 ( 2013) ISSN: 1449-1907 [Electronic] Australia
PMID23329887 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • TNF Receptor-Associated Factor 3
  • TNF Receptor-Associated Factor 5
  • TRAF3 protein, human
Topics
  • Adult
  • Female
  • Humans
  • Inflammatory Bowel Diseases (genetics, metabolism, pathology)
  • Intestinal Mucosa (metabolism)
  • Male
  • Middle Aged
  • Mucous Membrane (metabolism, pathology)
  • TNF Receptor-Associated Factor 3 (blood, genetics)
  • TNF Receptor-Associated Factor 5 (blood, genetics)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: